Inj w/fluor eval cv device
Choose 36597 when the catheter is repositioned under fluoroscopy. Choose 36598 for contrast injection to evaluate the device without repositioning.
CMS RVU26D · Effective 2026-10-01
Reports fluoroscopic repositioning of an existing central venous catheter when its tip has migrated and the catheter can be retained. Compare 36597 office and facility rates across CMS payment localities in Delaware.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
Delaware has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
$111.76
1 of 1 localities have a supported rate.
Payment area: Delaware
One mapped payment locality.
$51.70
1 of 1 localities have a supported rate.
Payment area: Delaware
One mapped payment locality.
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Vascular access
Reports fluoroscopic repositioning of an existing central venous catheter when its tip has migrated and the catheter can be retained.
This procedure moves a previously placed central venous catheter back into an appropriate position under fluoroscopic guidance. A typical reason is a catheter tip that has migrated into the internal jugular vein. An interventional radiologist or other clinician performing vascular access procedures manipulates the existing catheter while viewing its position, rather than inserting a new one. The service is commonly performed in an interventional radiology suite.
Report 36597 when the record documents that the existing catheter was actually repositioned, including its position before and after manipulation. An injection performed only to evaluate the device is a different service; replacing the catheter also calls for a different code. CMS assigns a 0-day global period, so routine preoperative and postoperative care on the procedure date is included. If multiple procedures are performed in the same session, CMS pays the highest-valued procedure in full and others at 50%. Modifier 50 is inappropriate. CMS does not pay an assistant at surgery for this service, and co-surgeon and team-surgery billing are not permitted.
772
Medicare services in 2024 · #3188 by national volume
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Office rates for Delaware, from the same CMS release.
Inj w/fluor eval cv device
Choose 36597 when the catheter is repositioned under fluoroscopy. Choose 36598 for contrast injection to evaluate the device without repositioning.
36597 retains and repositions the existing catheter. 36581 describes replacement of a tunneled central venous catheter.
36597 corrects the position of an existing catheter; 36584 describes complete PICC replacement.
36597 addresses catheter position by moving the catheter. 36593 addresses an obstructed device through drug instillation.
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Office / nonfacility
$111.76
Facility
$51.70
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for 36597 in Delaware.
PPRRVU2026_Oct_nonQPP.csv
4,535
GPCI2026.csv
40
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 1.18 | × 1.005 | 1.1859 |
| Practice expense | 2.05 | × 0.988 | 2.0254 |
| Malpractice | 0.15 | × 0.899 | 0.1348 |
| Total RVUs | 3.3461 | ||
| Conversion factor | × 33.4009 | ||
Office / nonfacility rate, Delaware$111.76
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 1.18 | 1.005 |
| Practice expense | 2.05 | 0.988 |
| Malpractice | 0.15 | 0.899 |
(1.18 × 1.005 + 2.05 × 0.988 + 0.15 × 0.899) × $33.4009 = $111.76
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 1.18 | 1.005 |
| Practice expense | 0.23 | 0.988 |
| Malpractice | 0.15 | 0.899 |
(1.18 × 1.005 + 0.23 × 0.988 + 0.15 × 0.899) × $33.4009 = $51.70
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
Report 36597 when the existing catheter is moved to correct its position. If the clinician injects contrast to evaluate the device without repositioning it, consider 36598 instead.
Replacement is different from repositioning the retained catheter. Select the replacement code for the type of central venous access device and the work performed.
The procedure note should identify the existing catheter, describe the malposition and the manipulation performed, and record the resulting position.
Fluoroscopic guidance is part of this repositioning procedure. CMS also includes routine preoperative and postoperative care on the procedure date in its 0-day global period.
In a same-session multiple-procedure claim, CMS pays the highest-valued procedure in full and others at 50%. Modifier 50 is inappropriate; CMS does not pay an assistant at surgery and does not permit co-surgeons or team surgery for 36597.
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.